Skip to main content
Erschienen in: International Journal of Hematology 5/2008

01.12.2008 | Original Article

Defects of FA/BRCA pathway in lymphoma cell lines

verfasst von: Hui Xiao, Ke Jian Zhang, Bing Xia

Erschienen in: International Journal of Hematology | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

The aim was to find the possible relationship between defects in the FA/BRCA pathway of genomic maintenance and potential pathogenesis of T and B cell lymphoma. We screened 29 cell lines derived from diverse subtypes of lymphoma for possible FA pathway defects. The results indicated: no defect in FANCD2 ubiquitination, BRCA2 and FANCJ expression; absence of FANCN protein in three cell lines: HT, Sudhl4 and JEKO-1. This absence was correlated with enhanced MMC-induced G2 arrest, growth inhibition and high chromosomal breakage rate in the three cell lines. We only found one substitution in HT and JEKO-1 exon-5a fragment: c.1769C > T, p. A590V. But in another lymphoma cell line Sudhl4 with FANCN absence, we have not found any mutation. In conclusion, this mutation maybe the reason which caused FANCN protein expression absent or made the protein very unstable and lose its function in HT and JEKO-1 cell lines.
Literatur
6.
Zurück zum Zitat Reid S, Schindler D, Hanenberg H, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39:162–4. doi:10.1038/ng1947.CrossRefPubMed Reid S, Schindler D, Hanenberg H, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39:162–4. doi:10.​1038/​ng1947.CrossRefPubMed
8.
Zurück zum Zitat Levitus M, Waisfisz Q, Godthelp BC, et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J Nat Genet. 2005;37:934–5. doi:10.1038/ng1625.CrossRef Levitus M, Waisfisz Q, Godthelp BC, et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J Nat Genet. 2005;37:934–5. doi:10.​1038/​ng1625.CrossRef
13.
Zurück zum Zitat Joenje H, Lo Ten Foe JR, Oostra AB, et al. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood. 1995;86:2156–60.PubMed Joenje H, Lo Ten Foe JR, Oostra AB, et al. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood. 1995;86:2156–60.PubMed
14.
Zurück zum Zitat Hogervorst FB, Nederlof PM, Gille JJ, et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res. 2003;63:1449–53.PubMed Hogervorst FB, Nederlof PM, Gille JJ, et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res. 2003;63:1449–53.PubMed
15.
Zurück zum Zitat Taniguchi T, Tischkowitz M, Ameziane N, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med. 2003;9:568–74. doi:10.1038/nm852.CrossRefPubMed Taniguchi T, Tischkowitz M, Ameziane N, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med. 2003;9:568–74. doi:10.​1038/​nm852.CrossRefPubMed
22.
Zurück zum Zitat van Der Heijden MS, Yeo CJ, Hruban RH, et al. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res. 2003;63:2585–8.PubMed van Der Heijden MS, Yeo CJ, Hruban RH, et al. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res. 2003;63:2585–8.PubMed
23.
Zurück zum Zitat van der Heijden MS, Brody JR, Gallmeier E, et al. Functional defects in the Fanconi anemia pathway in pancreatic cancer cells. Am J Pathol. 2004;165:651–7.CrossRefPubMedPubMedCentral van der Heijden MS, Brody JR, Gallmeier E, et al. Functional defects in the Fanconi anemia pathway in pancreatic cancer cells. Am J Pathol. 2004;165:651–7.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Couch FJ, Johnson MR, Rabe K, et al. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. Cancer Res. 2005;65:383–6.PubMed Couch FJ, Johnson MR, Rabe K, et al. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. Cancer Res. 2005;65:383–6.PubMed
Metadaten
Titel
Defects of FA/BRCA pathway in lymphoma cell lines
verfasst von
Hui Xiao
Ke Jian Zhang
Bing Xia
Publikationsdatum
01.12.2008
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 5/2008
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-008-0199-8

Weitere Artikel der Ausgabe 5/2008

International Journal of Hematology 5/2008 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.